Vaneck Pharmaceutical Etf Volatility
PPH Etf | USD 87.11 0.30 0.34% |
We consider VanEck Pharmaceutical very steady. VanEck Pharmaceutical ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0317, which indicates the etf had a 0.0317% return per unit of risk over the last 3 months. We have found thirty technical indicators for VanEck Pharmaceutical ETF, which you can use to evaluate the volatility of the etf. Please validate VanEck Pharmaceutical's Semi Deviation of 0.5087, coefficient of variation of 1472.37, and Risk Adjusted Performance of 0.0429 to confirm if the risk estimate we provide is consistent with the expected return of 0.0193%. Key indicators related to VanEck Pharmaceutical's volatility include:
60 Days Market Risk | Chance Of Distress | 60 Days Economic Sensitivity |
VanEck Pharmaceutical Etf volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of VanEck daily returns, and it is calculated using variance and standard deviation. We also use VanEck's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of VanEck Pharmaceutical volatility.
VanEck |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as VanEck Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of VanEck Pharmaceutical at lower prices. For example, an investor can purchase VanEck stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of VanEck Pharmaceutical's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with VanEck Etf
0.91 | XLV | Health Care Select | PairCorr |
0.86 | VHT | Vanguard Health Care | PairCorr |
0.75 | IBB | iShares Biotechnology ETF | PairCorr |
0.78 | XBI | SPDR SP Biotech | PairCorr |
0.81 | IHI | iShares Medical Devices | PairCorr |
0.96 | IXJ | iShares Global Healthcare | PairCorr |
0.91 | IYH | iShares Healthcare ETF | PairCorr |
0.91 | FHLC | Fidelity MSCI Health | PairCorr |
VanEck Pharmaceutical Market Sensitivity And Downside Risk
VanEck Pharmaceutical's beta coefficient measures the volatility of VanEck etf compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents VanEck etf's returns against your selected market. In other words, VanEck Pharmaceutical's beta of 0.63 provides an investor with an approximation of how much risk VanEck Pharmaceutical etf can potentially add to one of your existing portfolios. VanEck Pharmaceutical ETF exhibits very low volatility with skewness of 0.14 and kurtosis of -0.51. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure VanEck Pharmaceutical's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact VanEck Pharmaceutical's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze VanEck Pharmaceutical ETF Demand TrendCheck current 90 days VanEck Pharmaceutical correlation with market (NYSE Composite)VanEck Beta |
VanEck standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.61 |
It is essential to understand the difference between upside risk (as represented by VanEck Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of VanEck Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in vaneck etf tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in VanEck Pharmaceutical.
Using VanEck Put Option to Manage Risk
Put options written on VanEck Pharmaceutical grant holders of the option the right to sell a specified amount of VanEck Pharmaceutical at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of VanEck Etf cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge VanEck Pharmaceutical's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding VanEck Pharmaceutical will be realized, the loss incurred will be offset by the profits made with the option trade.
VanEck Pharmaceutical's PUT expiring on 2024-05-17
Profit |
VanEck Pharmaceutical Price At Expiration |
Current VanEck Pharmaceutical Insurance Chain
Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-05-17 PUT at $88.0 | -0.6645 | 0.1995 | 400 | 2024-05-17 | 0.95 - 1.45 | 2.15 | View |
Put | 2024-05-17 PUT at $87.0 | -0.447 | 0.2158 | 1500 | 2024-05-17 | 0.5 - 0.75 | 1.25 | View |
Put | 2024-05-17 PUT at $86.0 | -0.2636 | 0.1629 | 1454 | 2024-05-17 | 0.25 - 0.4 | 0.35 | View |
Put | 2024-05-17 PUT at $85.0 | -0.1502 | 0.1051 | 4 | 2024-05-17 | 0.1 - 0.25 | 0.35 | View |
VanEck Pharmaceutical ETF Etf Volatility Analysis
Volatility refers to the frequency at which VanEck Pharmaceutical etf price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with VanEck Pharmaceutical's price changes. Investors will then calculate the volatility of VanEck Pharmaceutical's etf to predict their future moves. A etf that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A etf with relatively stable price changes has low volatility. A highly volatile etf is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of VanEck Pharmaceutical's volatility:
Historical Volatility
This type of etf volatility measures VanEck Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict VanEck Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the etf.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for VanEck Pharmaceutical's current market price. This means that the etf will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on VanEck Pharmaceutical's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. VanEck Pharmaceutical ETF Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
VanEck Pharmaceutical Projected Return Density Against Market
Considering the 90-day investment horizon VanEck Pharmaceutical has a beta of 0.6295 indicating as returns on the market go up, VanEck Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding VanEck Pharmaceutical ETF will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to VanEck Pharmaceutical or VanEck sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that VanEck Pharmaceutical's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a VanEck etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
VanEck Pharmaceutical ETF has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
Returns |
What Drives a VanEck Pharmaceutical Price Volatility?
Several factors can influence a etf's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.VanEck Pharmaceutical Etf Risk Measures
Considering the 90-day investment horizon the coefficient of variation of VanEck Pharmaceutical is 3155.05. The daily returns are distributed with a variance of 0.37 and standard deviation of 0.61. The mean deviation of VanEck Pharmaceutical ETF is currently at 0.49. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.63
α | Alpha over NYSE Composite | -0.01 | |
β | Beta against NYSE Composite | 0.63 | |
σ | Overall volatility | 0.61 | |
Ir | Information ratio | -0.06 |
VanEck Pharmaceutical Etf Return Volatility
VanEck Pharmaceutical historical daily return volatility represents how much of VanEck Pharmaceutical etf's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The Etf has volatility of 0.6096% on return distribution over 90 days investment horizon. By contrast, NYSE Composite accepts 0.6197% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About VanEck Pharmaceutical Volatility
Volatility is a rate at which the price of VanEck Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of VanEck Pharmaceutical may increase or decrease. In other words, similar to VanEck's beta indicator, it measures the risk of VanEck Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of VanEck Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.3 ways to utilize VanEck Pharmaceutical's volatility to invest better
Higher VanEck Pharmaceutical's etf volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of VanEck Pharmaceutical ETF etf is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. VanEck Pharmaceutical ETF etf volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of VanEck Pharmaceutical ETF investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in VanEck Pharmaceutical's etf can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of VanEck Pharmaceutical's etf relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
VanEck Pharmaceutical Investment Opportunity
NYSE Composite has a standard deviation of returns of 0.62 and is 1.02 times more volatile than VanEck Pharmaceutical ETF. 5 percent of all equities and portfolios are less risky than VanEck Pharmaceutical. You can use VanEck Pharmaceutical ETF to protect your portfolios against small market fluctuations. The etf experiences a normal downward trend and little activity. Check odds of VanEck Pharmaceutical to be traded at $86.24 in 90 days.Poor diversification
The correlation between VanEck Pharmaceutical ETF and NYA is 0.63 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and NYA in the same portfolio, assuming nothing else is changed.
VanEck Pharmaceutical Additional Risk Indicators
The analysis of VanEck Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in VanEck Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of VanEck Pharmaceutical etf's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | 0.0429 | |||
Market Risk Adjusted Performance | 0.0622 | |||
Mean Deviation | 0.5197 | |||
Semi Deviation | 0.5087 | |||
Downside Deviation | 0.5668 | |||
Coefficient Of Variation | 1472.37 | |||
Standard Deviation | 0.6312 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential etfs, we recommend comparing similar etfs with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
VanEck Pharmaceutical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against VanEck Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. VanEck Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, VanEck Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to VanEck Pharmaceutical ETF.
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.